Investigating a potential treatment option for parainfluenza virus in immunocompromised patients
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Lower Respiratory Tract Infection Parainfluenza Immunocompromised COVID-19 PIV LRTI COVID19 SARS-CoV-2 Coronavirus Ansun Infections Communicable Diseases Respiratory Tract Infections Paramyxoviridae Infections DAS181 DAS181 COVID-19 DAS181 OL
Lead Scientists at University of California Health
- accepting new patients
- Start Date
- Completion Date
- Ansun Biopharma, Inc.
- Phase 3
- Study Type
- Last Updated